To gain a better understanding of the relationship between neuroinflammation and the development of MDD, it is useful to investigate whether increased levels of MCP-2 and MIP-1β are present before the onset of depressive symptoms, or depression causes to elevate the levels. This evidence concerns the gene CCL8 and depressive symptom measurement.